Boston Sci gets go-ahead to sell MRI-compatible spine stimulators

Dave Pearson | | Health Imaging | Diagnostic Imaging

Boston Scientific has received FDA approval to go to market with an MRI-compatible version of one of its implantable spinal-cord stimulators used to relieve chronic pain.

Spinal cord stimulators deliver electrical pulses to block pain signals traveling to the brain. The new device, called the Precision Montage MRI Spinal Cord Stimulator (SCS), enables safe access to full-body scans in a 1.5T environment when conditions of use are met, according to an announcement from the Marlborough, Mass.-based company.

Boston Scientific says its new SCS system expands its suite of SCS products tapping the company’s trademarked Illumina 3D algorithm, which enables point-and-click pain targeting, as well as its multi-waveform technology, which is intended to respond to changes in pain over time.

The company says an analysis of registry information from 800 patients showed that 72 percent used multiple waveforms to customize their therapy and optimize pain relief.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.